APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amino Acid Metabolism Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amino Acid Metabolism Disorder Drug Market Outlook and Growth Opportunities 2026

19 December 2025193 pages

Choose your research edition.

Industry ResearchAmino Acid Metabolism Disorder Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Amino Acid Metabolism Disorder Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Amino Acid Metabolism Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amino Acid Metabolism Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Amino Acid Metabolism Disorder Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Amino Acid Metabolism Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amino Acid Metabolism Disorder Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amino Acid Metabolism Disorder Drug market include AMINO, BioMarin, DSM, Kyowa Hakko Kirin, Recordati, Shine Star (Hubei) Biological Engineering, Swedish Orphan Biovitrum, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Amino Acid Metabolism Disorder Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amino Acid Metabolism Disorder Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amino Acid Metabolism Disorder Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Amino Acid Metabolism Disorder Drug market.

Amino Acid Metabolism Disorder Drug Segment by Company

AMINO

BioMarin

DSM

Kyowa Hakko Kirin

Recordati

Shine Star (Hubei) Biological Engineering

Swedish Orphan Biovitrum

GlaxoSmithKline

Pfizer

Merck

Sanofi

Amino Acid Metabolism Disorder Drug Segment by Type

Folic Acid

Sapropterin Dihydrochloride

Vitamin D

Vitamin B6 & B12

Betaine

Thiamine

Carglumic Acid

Arginine

Others

Amino Acid Metabolism Disorder Drug Segment by Application

Argininosuccinic Acidemia

Citrullinemia

Homocystinuria

Maple Syrup Urine Disease

Phenylketonuria

Amino Acid Metabolism Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Amino Acid Metabolism Disorder Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Amino Acid Metabolism Disorder Drug key companies, revenue, market share, and recent developments.

3. To split the Amino Acid Metabolism Disorder Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Amino Acid Metabolism Disorder Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amino Acid Metabolism Disorder Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Amino Acid Metabolism Disorder Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amino Acid Metabolism Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amino Acid Metabolism Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amino Acid Metabolism Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amino Acid Metabolism Disorder Drug industry.

Chapter 3: Detailed analysis of Amino Acid Metabolism Disorder Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Amino Acid Metabolism Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Amino Acid Metabolism Disorder Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amino Acid Metabolism Disorder Drug Industry Trends Table 2. Amino Acid Metabolism Disorder Drug Industry Drivers Table 3. Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges Table 4. Amino Acid Metabolism Disorder Drug Industry Restraints Table 5. Global Amino Acid Metabolism Disorder Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amino Acid Metabolism Disorder Drug Revenue Share by Company (2021-2026) Table 7. Global Amino Acid Metabolism Disorder Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Amino Acid Metabolism Disorder Drug Key Company Manufacturing Base & Headquarters Table 9. Global Amino Acid Metabolism Disorder Drug Company, Product Type & Application Table 10. Global Amino Acid Metabolism Disorder Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Amino Acid Metabolism Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Folic Acid Table 15. Significant Companies of Sapropterin Dihydrochloride Table 16. Significant Companies of Vitamin D Table 17. Significant Companies of Vitamin B6 & B12 Table 18. Significant Companies of Betaine Table 19. Significant Companies of Thiamine Table 20. Significant Companies of Carglumic Acid Table 21. Significant Companies of Arginine Table 22. Significant Companies of Others Table 23. Global Amino Acid Metabolism Disorder Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2021-2026) & (US$ Million) Table 25. Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2027-2032) & (US$ Million) Table 26. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Type (2021-2026) Table 27. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Type (2027-2032) Table 28. Significant Companies of Argininosuccinic Acidemia Table 29. Significant Companies of Citrullinemia Table 30. Significant Companies of Homocystinuria Table 31. Significant Companies of Maple Syrup Urine Disease Table 32. Significant Companies of Phenylketonuria Table 33. Global Amino Acid Metabolism Disorder Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2021-2026) & (US$ Million) Table 35. Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2027-2032) & (US$ Million) Table 36. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Application (2021-2026) Table 37. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Application (2027-2032) Table 38. Global Amino Acid Metabolism Disorder Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2021-2026) & (US$ Million) Table 40. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Region (2021-2026) Table 41. Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2027-2032) & (US$ Million) Table 42. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Region (2027-2032) Table 43. Global Amino Acid Metabolism Disorder Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Amino Acid Metabolism Disorder Drug Sales Value by Country (2021-2026) & (US$ Million) Table 45. Global Amino Acid Metabolism Disorder Drug Sales Value Market Share by Country (2021-2026) Table 46. Global Amino Acid Metabolism Disorder Drug Sales Value by Country (2027-2032) & (US$ Million) Table 47. Global Amino Acid Metabolism Disorder Drug Sales Value Market Share by Country (2027-2032) Table 48. AMINO Company Information Table 49. AMINO Business Overview Table 50. AMINO Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. AMINO Amino Acid Metabolism Disorder Drug Product Portfolio Table 52. AMINO Recent Development Table 53. BioMarin Company Information Table 54. BioMarin Business Overview Table 55. BioMarin Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio Table 57. BioMarin Recent Development Table 58. DSM Company Information Table 59. DSM Business Overview Table 60. DSM Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. DSM Amino Acid Metabolism Disorder Drug Product Portfolio Table 62. DSM Recent Development Table 63. Kyowa Hakko Kirin Company Information Table 64. Kyowa Hakko Kirin Business Overview Table 65. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio Table 67. Kyowa Hakko Kirin Recent Development Table 68. Recordati Company Information Table 69. Recordati Business Overview Table 70. Recordati Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Recordati Amino Acid Metabolism Disorder Drug Product Portfolio Table 72. Recordati Recent Development Table 73. Shine Star (Hubei) Biological Engineering Company Information Table 74. Shine Star (Hubei) Biological Engineering Business Overview Table 75. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio Table 77. Shine Star (Hubei) Biological Engineering Recent Development Table 78. Swedish Orphan Biovitrum Company Information Table 79. Swedish Orphan Biovitrum Business Overview Table 80. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio Table 82. Swedish Orphan Biovitrum Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio Table 92. Pfizer Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Amino Acid Metabolism Disorder Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Merck Amino Acid Metabolism Disorder Drug Product Portfolio Table 97. Merck Recent Development Table 98. Sanofi Company Information Table 99. Sanofi Business Overview Table 100. Sanofi Amino Acid Metabolism Disorder Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio Table 102. Sanofi Recent Development Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Amino Acid Metabolism Disorder Drug Product Image Figure 2. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Amino Acid Metabolism Disorder Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Folic Acid Image Figure 8. Sapropterin Dihydrochloride Image Figure 9. Vitamin D Image Figure 10. Vitamin B6 & B12 Image Figure 11. Betaine Image Figure 12. Thiamine Image Figure 13. Carglumic Acid Image Figure 14. Arginine Image Figure 15. Others Image Figure 16. Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Amino Acid Metabolism Disorder Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Type (2021-2032) Figure 19. Argininosuccinic Acidemia Image Figure 20. Citrullinemia Image Figure 21. Homocystinuria Image Figure 22. Maple Syrup Urine Disease Image Figure 23. Phenylketonuria Image Figure 24. Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Amino Acid Metabolism Disorder Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Application (2021-2032) Figure 27. Global Amino Acid Metabolism Disorder Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Amino Acid Metabolism Disorder Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Amino Acid Metabolism Disorder Drug Sales Value (2021-2032) & (US$ Million) Figure 30. North America Amino Acid Metabolism Disorder Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Amino Acid Metabolism Disorder Drug Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Amino Acid Metabolism Disorder Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Amino Acid Metabolism Disorder Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Amino Acid Metabolism Disorder Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Amino Acid Metabolism Disorder Drug Sales Value (2021-2032) & (US$ Million) Figure 36. South America Amino Acid Metabolism Disorder Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Amino Acid Metabolism Disorder Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Amino Acid Metabolism Disorder Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Years Considered Figure 124. Research Process Figure 125. Key Executives Interviewed

Scope & coverage.

Types
  • Folic Acid
  • Sapropterin Dihydrochloride
  • Vitamin D
  • Vitamin B6 & B12
  • Betaine
  • Thiamine
  • Carglumic Acid
  • Arginine
  • Others
Applications
  • Argininosuccinic Acidemia
  • Citrullinemia
  • Homocystinuria
  • Maple Syrup Urine Disease
  • Phenylketonuria
Companies covered
  • AMINO
  • BioMarin
  • DSM
  • Kyowa Hakko Kirin
  • Recordati
  • Shine Star (Hubei) Biological Engineering
  • Swedish Orphan Biovitrum
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amino Acid Metabolism Disorder Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Amino Acid Metabolism Disorder Drug Market Dynamics
  1. 2.1 Amino Acid Metabolism Disorder Drug Industry Trends
  2. 2.2 Amino Acid Metabolism Disorder Drug Industry Drivers
  3. 2.3 Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Amino Acid Metabolism Disorder Drug Industry Restraints
3 Amino Acid Metabolism Disorder Drug Market by Company
  1. 3.1 Global Amino Acid Metabolism Disorder Drug Company Revenue Ranking in 2025
  2. 3.2 Global Amino Acid Metabolism Disorder Drug Revenue by Company (2021-2026)
  3. 3.3 Global Amino Acid Metabolism Disorder Drug Company Ranking (2024-2026)
  4. 3.4 Global Amino Acid Metabolism Disorder Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Amino Acid Metabolism Disorder Drug Company Product Type and Application
  6. 3.6 Global Amino Acid Metabolism Disorder Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Amino Acid Metabolism Disorder Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Amino Acid Metabolism Disorder Drug Market by Type
  1. 4.1 Amino Acid Metabolism Disorder Drug Type Introduction
  2. 4.1.1 Folic Acid
  3. 4.1.2 Sapropterin Dihydrochloride
  4. 4.1.3 Vitamin D
  5. 4.1.4 Vitamin B6 & B12
  6. 4.1.5 Betaine
  7. 4.1.6 Thiamine
  8. 4.1.7 Carglumic Acid
  9. 4.1.8 Arginine
  10. 4.1.9 Others
  11. 4.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Type
  12. 4.2.1 Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Type (2021-2032)
  14. 4.2.3 Global Amino Acid Metabolism Disorder Drug Sales Value Share by Type (2021-2032)
5 Amino Acid Metabolism Disorder Drug Market by Application
  1. 5.1 Amino Acid Metabolism Disorder Drug Application Introduction
  2. 5.1.1 Argininosuccinic Acidemia
  3. 5.1.2 Citrullinemia
  4. 5.1.3 Homocystinuria
  5. 5.1.4 Maple Syrup Urine Disease
  6. 5.1.5 Phenylketonuria
  7. 5.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Application
  8. 5.2.1 Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Application (2021-2032)
  10. 5.2.3 Global Amino Acid Metabolism Disorder Drug Sales Value Share by Application (2021-2032)
6 Amino Acid Metabolism Disorder Drug Regional Value Analysis
  1. 6.1 Global Amino Acid Metabolism Disorder Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Amino Acid Metabolism Disorder Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amino Acid Metabolism Disorder Drug Sales Value (2021-2032)
  7. 6.3.2 North America Amino Acid Metabolism Disorder Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Amino Acid Metabolism Disorder Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Amino Acid Metabolism Disorder Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Amino Acid Metabolism Disorder Drug Sales Value (2021-2032)
  16. 6.6.2 South America Amino Acid Metabolism Disorder Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Sales Value Share by Country, 2025 VS 2032
7 Amino Acid Metabolism Disorder Drug Country-level Value Analysis
  1. 7.1 Global Amino Acid Metabolism Disorder Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Amino Acid Metabolism Disorder Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Amino Acid Metabolism Disorder Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Amino Acid Metabolism Disorder Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Amino Acid Metabolism Disorder Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Amino Acid Metabolism Disorder Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AMINO
  2. 8.1.1 AMINO Company Information
  3. 8.1.2 AMINO Business Overview
  4. 8.1.3 AMINO Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AMINO Amino Acid Metabolism Disorder Drug Product Portfolio
  6. 8.1.5 AMINO Recent Developments
  7. 8.2 BioMarin
  8. 8.2.1 BioMarin Company Information
  9. 8.2.2 BioMarin Business Overview
  10. 8.2.3 BioMarin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio
  12. 8.2.5 BioMarin Recent Developments
  13. 8.3 DSM
  14. 8.3.1 DSM Company Information
  15. 8.3.2 DSM Business Overview
  16. 8.3.3 DSM Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DSM Amino Acid Metabolism Disorder Drug Product Portfolio
  18. 8.3.5 DSM Recent Developments
  19. 8.4 Kyowa Hakko Kirin
  20. 8.4.1 Kyowa Hakko Kirin Company Information
  21. 8.4.2 Kyowa Hakko Kirin Business Overview
  22. 8.4.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio
  24. 8.4.5 Kyowa Hakko Kirin Recent Developments
  25. 8.5 Recordati
  26. 8.5.1 Recordati Company Information
  27. 8.5.2 Recordati Business Overview
  28. 8.5.3 Recordati Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Recordati Amino Acid Metabolism Disorder Drug Product Portfolio
  30. 8.5.5 Recordati Recent Developments
  31. 8.6 Shine Star (Hubei) Biological Engineering
  32. 8.6.1 Shine Star (Hubei) Biological Engineering Company Information
  33. 8.6.2 Shine Star (Hubei) Biological Engineering Business Overview
  34. 8.6.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio
  36. 8.6.5 Shine Star (Hubei) Biological Engineering Recent Developments
  37. 8.7 Swedish Orphan Biovitrum
  38. 8.7.1 Swedish Orphan Biovitrum Company Information
  39. 8.7.2 Swedish Orphan Biovitrum Business Overview
  40. 8.7.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio
  42. 8.7.5 Swedish Orphan Biovitrum Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Merck
  56. 8.10.1 Merck Company Information
  57. 8.10.2 Merck Business Overview
  58. 8.10.3 Merck Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merck Amino Acid Metabolism Disorder Drug Product Portfolio
  60. 8.10.5 Merck Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst